Tamsulosin

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3684 publications

Evaluation of Preoperative Tamsulosin Use in Ureteroscopic Holmium Laser Lithotripsy for Elderly Patients with Ureteral Stones.

Evaluation of Preoperative Tamsulosin Use in Ureteroscopic Holmium Laser Lithotripsy for Elderly Patients with Ureteral Stones.

Journal: Journal of visualized experiments : JoVE
Published: June 22, 2026

Damp scalp application enhances follicular delivery of dutasteride loaded in liposomes compared to dry scalp.

Damp scalp application enhances follicular delivery of dutasteride loaded in liposomes compared to dry scalp.

Journal: Therapeutic delivery
Published: June 19, 2026

Baseline Gut Microbiome-Metabolome Signatures Are Associated with Drinking Severity and Reduction Following Dutasteride Treatment in Alcohol Use Disorder.

Baseline Gut Microbiome-Metabolome Signatures Are Associated with Drinking Severity and Reduction Following Dutasteride Treatment in Alcohol Use Disorder.

Journal: medRxiv : the preprint server for health sciences
Published: June 12, 2026

Analysis of the Effect of Stepwise Refined Nursing on the Severity of Ureteral Stent-Related Symptom Clusters After Flexible Ureteroscopic Lithotripsy.

Analysis of the Effect of Stepwise Refined Nursing on the Severity of Ureteral Stent-Related Symptom Clusters After Flexible Ureteroscopic Lithotripsy.

Journal: Archivos espanoles de urologia
Published: June 10, 2026

A randomized controlled trial comparing alpha-blocker (tamsulosin) and a phyto-complex (Solidago virga-aurea, Phyllantus niruri, Epilobium angustifolium, Peumus boldus and Ononis spinosa) in the treatment of ureteral stent-related symptoms.

A randomized controlled trial comparing alpha-blocker (tamsulosin) and a phyto-complex (Solidago virga-aurea, Phyllantus niruri, Epilobium angustifolium, Peumus boldus and Ononis spinosa) in the treatment of ureteral stent-related symptoms.

Journal: Urologia
Published: June 05, 2026

Post-extracorporeal Membrane Oxygenation (ECMO) Bilateral Urolithiasis in an Adolescent With B-cell Acute Lymphoblastic Leukemia (ALL): A Case Report.

Post-extracorporeal Membrane Oxygenation (ECMO) Bilateral Urolithiasis in an Adolescent With B-cell Acute Lymphoblastic Leukemia (ALL): A Case Report.

Journal: Cureus
Published: May 08, 2026

AI-driven credibility profiling of real-world patient experiences suggests overlooked kidney stone therapies warrant further investigation.

AI-driven credibility profiling of real-world patient experiences suggests overlooked kidney stone therapies warrant further investigation.

Journal: Research square
Published: April 29, 2026

The effect of dutasteride on storage symptoms in men with lower urinary tract symptoms: a REDUCE trial analysis.

The effect of dutasteride on storage symptoms in men with lower urinary tract symptoms: a REDUCE trial analysis.

Journal: The aging male : the official journal of the International Society for the Study of the Aging Male
Published: April 21, 2026

5 Alpha Reductase Inhibitors (5ARIs) Monotherapy and Combinations: Current Role in Benign Prostatic Hyperplasia (BPH) Management.

5 Alpha Reductase Inhibitors (5ARIs) Monotherapy and Combinations: Current Role in Benign Prostatic Hyperplasia (BPH) Management.

Journal: Medicina (Kaunas, Lithuania)
Published: April 09, 2026

Double versus standard dose of tamsulosin with solifenacin for management of ureteral stent related symptoms.

Double versus standard dose of tamsulosin with solifenacin for management of ureteral stent related symptoms.

Journal: Arab journal of urology
Published: April 06, 2026

Selective one-pot fluorescent probing technique for determination of tolterodine in dosage forms, content uniformity, and human plasma via coumarin synthesis.

Selective one-pot fluorescent probing technique for determination of tolterodine in dosage forms, content uniformity, and human plasma via coumarin synthesis.

Journal: Talanta
Published: March 25, 2026

Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS).

Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS).

Journal: The aging male : the official journal of the International Society for the Study of the Aging Male
Published: March 24, 2026
Showing 1-12 of 3,684

Last Updated: 06/30/2026